Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes

Cardiovasc Res. 1998 Oct;40(1):174-81. doi: 10.1016/s0008-6363(98)00171-0.

Abstract

Objective: The present study investigated whether activation of phosphatidylinositol 3-kinase (PI3-kinase) is involved in the stimulation of hypertrophic growth of adult ventricular cardiomyocytes under alpha- or beta-adrenoceptor stimulation.

Methods: Adult ventricular rat cardiomyocytes were used either directly after isolation (day 1 culture) or after cultivation for 6 days in presence of 20% fetal calf serum (day 7 culture). PI3-kinase activity was determined in extracts of cardiomyocytes after immunoprecipitation with an antibody against the p85 subunit of PI3-kinase. The influence of PI3-kinase inhibition on myocardial growth was determined using the specific PI3-kinase inhibitors wortmannin and LY294002.

Results: In day 1 cultures alpha-adrenoceptor stimulation, but not beta-adrenoceptor stimulation caused activation of PI3-kinase. In response to alpha-adrenoceptor stimulation but not beta-adrenoceptor stimulation an acceleration of protein synthesis (incorporation of 14C-phenylalanine) and an increase in the total masses of cellular protein and RNA was observed. In these cultures inhibition of PI3-kinase attenuated the acceleration of protein synthesis and the increase in cellular masses of protein or RNA in response to alpha-adrenoceptor stimulation. In day 7 cultures alpha- and beta-adrenoceptor stimulation caused activation of PI3-kinase and increased protein synthesis. In these cultures inhibition of PI3-kinase attenuated the growth response to alpha- and beta-adrenoceptor stimulation.

Conclusions: PI3-kinase activation via protein kinase C-dependent or cAMP-dependent pathways is required for hypertrophic growth of adult cardiomyocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Androstadienes / pharmacology
  • Animals
  • Cardiomegaly / enzymology*
  • Cardiomegaly / metabolism
  • Cardiomegaly / pathology
  • Cells, Cultured
  • Chromatography, Thin Layer
  • Chromones / pharmacology
  • DNA / analysis
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Isoproterenol / pharmacology
  • Male
  • Morpholines / pharmacology
  • Myocardium / enzymology
  • Myocardium / metabolism
  • Myocardium / pathology*
  • Phenylalanine / metabolism
  • Phenylephrine / pharmacology
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Biosynthesis
  • RNA / analysis
  • Rats
  • Rats, Wistar
  • Signal Transduction*
  • Stimulation, Chemical
  • Time Factors
  • Uridine / metabolism
  • Wortmannin

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • Androstadienes
  • Chromones
  • Enzyme Inhibitors
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Phenylephrine
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Phenylalanine
  • RNA
  • DNA
  • Isoproterenol
  • Uridine
  • Wortmannin